Business Description
Realcan Pharmaceutical Group Co Ltd
NAICS : 325412
ISIN : CNE1000013X5
Share Class Description:
SZSE:002589: Class ACompare
Compare
Traded in other countries / regions
002589.China IPO Date
2011-06-10Description
Realcan Pharmaceutical Group Co Ltd is a Chinese company engaged in direct pharmaceuticals distribution services. The company's main business is divided into the Drug, vaccine, medical device circulation service; Medical industry third-party logistics; Medical information service; Medical logistics service; Chinese medicine plate; Hospital management sector; Medical industry research and development production sector; and Medical industry financial sector.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.44 | |||||
| Equity-to-Asset | 0.32 | |||||
| Debt-to-Equity | 0.71 | |||||
| Debt-to-EBITDA | -2.46 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 0.39 | |||||
| Beneish M-Score | -2.85 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -29.2 | |||||
| 3-Year EPS without NRI Growth Rate | 6.1 | |||||
| 3-Year FCF Growth Rate | -32.4 | |||||
| 3-Year Book Growth Rate | -9 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 38.67 | |||||
| 9-Day RSI | 38.47 | |||||
| 14-Day RSI | 40.76 | |||||
| 6-1 Month Momentum % | -14.63 | |||||
| 12-1 Month Momentum % | -23.71 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.05 | |||||
| Quick Ratio | 0.99 | |||||
| Cash Ratio | 0.49 | |||||
| Days Inventory | 51.02 | |||||
| Days Sales Outstanding | 233.2 | |||||
| Days Payable | 391.48 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Dividend Growth Rate | -44.3 | |||||
| Shareholder Yield % | 20.23 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 8.79 | |||||
| Operating Margin % | -4.24 | |||||
| Net Margin % | -24.92 | |||||
| FCF Margin % | 7.75 | |||||
| ROE % | -32.55 | |||||
| ROA % | -9.66 | |||||
| ROIC % | -3.11 | |||||
| ROC (Joel Greenblatt) % | -66.61 | |||||
| ROCE % | -24.5 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shiller PE Ratio | 35.29 | |||||
| PS Ratio | 0.51 | |||||
| PB Ratio | 0.68 | |||||
| Price-to-Tangible-Book | 0.78 | |||||
| Price-to-Free-Cash-Flow | 6.21 | |||||
| Price-to-Operating-Cash-Flow | 6.91 | |||||
| EV-to-EBIT | -1.25 | |||||
| EV-to-EBITDA | -1.25 | |||||
| EV-to-Revenue | 0.26 | |||||
| EV-to-FCF | 3.39 | |||||
| Price-to-Projected-FCF | 1.05 | |||||
| Price-to-Median-PS-Value | 0.83 | |||||
| Price-to-Net-Current-Asset-Value | 19 | |||||
| Earnings Yield (Greenblatt) % | -80 | |||||
| FCF Yield % | 15.67 | |||||
| Forward Rate of Return (Yacktman) % | -28.83 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Realcan Pharmaceutical Group Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 7,519.624 | ||
| EPS (TTM) (Â¥) | -1.271 | ||
| Beta | 0.53 | ||
| Volatility % | 29.66 | ||
| 14-Day RSI | 40.76 | ||
| 14-Day ATR (Â¥) | 0.129167 | ||
| 20-Day SMA (Â¥) | 2.726 | ||
| 12-1 Month Momentum % | -23.71 | ||
| 52-Week Range (Â¥) | 2.05 - 3.96 | ||
| Shares Outstanding (Mil) | 1,504.71 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Realcan Pharmaceutical Group Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Realcan Pharmaceutical Group Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Realcan Pharmaceutical Group Co Ltd Frequently Asked Questions
What is Realcan Pharmaceutical Group Co Ltd(SZSE:002589)'s stock price today?
The current price of SZSE:002589 is ¥2.47. The 52 week high of SZSE:002589 is ¥3.96 and 52 week low is ¥2.05.
When is next earnings date of Realcan Pharmaceutical Group Co Ltd(SZSE:002589)?
The next earnings date of Realcan Pharmaceutical Group Co Ltd(SZSE:002589) is .
Does Realcan Pharmaceutical Group Co Ltd(SZSE:002589) pay dividends? If so, how much?
Realcan Pharmaceutical Group Co Ltd(SZSE:002589) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers